There is a loss of time for patient care and a huge increase in time burden outside the visit for doctors and pharmacists. Another major insurance change coming next year will affect another large swath of Dushays patients: In January, BCBS Massachusetts will be excluding all GLP-1s from coverage for treatment of obesity, reserving coverage for these drugs only when indicated to treat type 2 diabetes
Without insurance coverage, a year of GLP-1 treatment can cost $15,000 to $18,000
Limitless Life Semaglutide While the cost and quality of weight loss peptides can vary greatly by region and source, Limitless Life offers semaglutide of verified purity at relatively low costs
At 5900 Health, we're committed to providing you with the tools, guidance, and support to achieve and maintain your health goals
Wegovy is especially approved for weight loss, making it a highly effective obesity treatment, whereas Ozempic is generally used for type 2 diabetes